Identification of Frailty Using a Claims-Based Frailty Index in the CoreValve Studies: Findings from the

Jordan B Strom1,2,3, Jiaman Xu2,3, Ariela R Orkaby3,4

  • 1Department of Medicine Cardiovascular Division Beth Israel Deaconess Medical Center Boston MA.

Insights

Claims-based frailty indices (CFIs) in aortic valve disease patients identify individuals with worse health impairments and higher mortality risk. This retrospective method offers valuable prognostic information when in-person frailty assessments are unavailable.

Area of Science:

  • Gerontology and Geriatric Medicine
  • Cardiovascular Medicine
  • Health Services Research

Background:

  • The relationship between claims-based frailty indices (CFIs) and validated, in-person frailty assessments in aortic valve disease is not well understood.
  • CFIs may offer a method for retrospective frailty ascertainment when direct measurement is not feasible.

Purpose of the Study:

  • To evaluate the association between a claims-based frailty index (Johns Hopkins CFI) and clinical outcomes in patients undergoing aortic valve procedures.
  • To determine if CFIs can identify patients with worse frailty status and predict adverse events.

Main Methods:

  • Adults aged ≥65 years from the US CoreValve Studies were linked to Medicare inpatient claims (2011-2015).
  • The Johns Hopkins CFI, based on the Fried index, was generated for each participant.
  • Association between CFI tertiles and outcomes (mortality, bleeding, MACE, hospitalization) was analyzed.

Main Results:

  • Higher CFI tertiles correlated with greater impairments in nutrition, disability, cognition, and self-rated health.
  • One-year all-cause mortality significantly increased with higher CFI tertiles (HR 1.73 for highest vs. lowest tertile, P<0.001).
  • Secondary outcomes, including bleeding, major adverse cardiovascular and cerebrovascular events (MACE), and hospitalization, were more frequent in higher CFI tertiles, independent of clinical risk scores.

Conclusions:

  • A claims-based frailty index (CFI) effectively identifies patients with worse frailty, disability, and cognitive/nutritional deficits in aortic valve disease.
  • Higher CFI scores are independently associated with increased risks of mortality, hospitalization, bleeding, and MACE.
  • While not a substitute for in-person assessments, CFIs provide valid and prognostically relevant frailty information for retrospective analysis.

Related Concept Videos

Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
157
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
74
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
91
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
72
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
104
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
43